A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023
Monoamine oxidases (MAOs) are a family of flavin adenine dinucleotide-dependent enzymes that catalyze the oxidative deamination of a wide range of endogenous and exogenous amines. Multiple neurological conditions, including Parkinson's disease (PD) and Alzheimer's disease (AD), are closely...
Saved in:
Main Authors: | Reshma Susan Ipe (Author), Sunil Kumar (Author), Feba Benny (Author), Jayalakshmi Jayan (Author), Amritha Manoharan (Author), Sachitra Thazhathuveedu Sudevan (Author), Ginson George (Author), Prashant Gahtori (Author), Hoon Kim (Author), Bijo Mathew (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KIF1A-Associated Neurological Disorder: An Overview of a Rare Mutational Disease
by: Ayushi Nair, et al.
Published: (2023) -
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
by: Piero Sestili, et al.
Published: (2020) -
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
by: Payyalot Koyiparambath Vishal, et al.
Published: (2021) -
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy
by: Irene Pachón-Angona, et al.
Published: (2019) -
Design and synthesis of chromone-nitrogen mustard derivatives and evaluation of anti-breast cancer activity
by: Jianan Sun, et al.
Published: (2022)